数据中心
龙虎榜
大单追踪
资金流向
业绩预告
新股申购
行情中心
沪深市场
香港市场
美国市场
全球市场
行业风云
全球市场
向上 向下

   CYRX
-- -- --

今开：-- 昨收：-- 最高：-- 最低：--
成交量：--万手 市盈率：-- 总市值($)：-- 换手率：--
加入自选股

首页概览 公司概况 财务分析 高管介绍 股本结构 公司新闻

股本结构

单位：万股
公告日期 2024-04-03 2024-03-13 2024-03-13 2023-11-09 2023-08-09 2023-05-04
证券总股本 4916.45 4897.75 4897.10 4896.37 4887.90 4554.53
普通股本 4916.45 4897.75 4897.10 4896.37 4887.90 4554.53
优先股 未披露 未披露 20.00 20.00 20.00 未披露
其他 未披露 未披露 未披露 未披露 未披露 未披露
变动日期 2024-03-18 2024-02-23 2023-12-31 2023-09-30 2023-06-30 2023-04-21
注释：中概股证券总股本=普通股股本/ 存托凭证比例

历史变动

公告日期 变动后普通股本（万股） 变动后优先股（万股） 变动原因 变动日期
2024-04-03 4916.45 未披露 定期报告 2024-03-18
2024-03-13 4897.75 未披露 定期报告 2024-02-23
2024-03-13 4897.10 20.00
更多>>
From December 31, 2022 to December 31, 2023 Proceeds from exercise of stock options Vesting of restricted stock units
2023-12-31
2023-11-09 4896.37 20.00
更多>>
From June 30, 2023 to September 30, 2023 Vesting of restricted stock units Proceeds from exercise of stock options
2023-09-30
2023-08-09 4887.90 20.00
更多>>
From March 31, 2023 to June 30, 2023 Proceeds from exercise of stock options Vesting of restricted stock units
2023-06-30
2023-05-04 4554.53 未披露 定期报告 2023-04-21
2023-05-04 4850.14 20.00
更多>>
From December 31, 2022 to March 31, 2023 Proceeds from exercise of stock options Vesting of restricted stock units
2023-03-31
2023-03-31 4841.73 20.00 定期报告 2023-03-15
2023-02-28 4833.58 未披露 定期报告 2023-02-17
2023-02-28 4833.43 20.00
更多>>
From December 31, 2021 to December 31, 2022 Issuance of common stock for Cell&Co acquisition Vesting of restricted stock units Proceeds from exercise of stock options Repurchase of common stock
2022-12-31
2022-11-04 4899.98 未披露 定期报告 2022-10-28
2022-11-04 4855.84 20.00
更多>>
From June 30, 2022 to September 30, 2022 Vesting of restricted stock units Proceeds from exercise of stock options
2022-09-30
2022-08-04 4848.98 未披露 定期报告 2022-07-29
2022-08-04 4848.25 20.00
更多>>
From March 31, 2022 to June 30, 2022 Issuance of common stock for Cell&Co acquisition Vesting of restricted stock units Proceeds from exercise of stock options Repurchase of common stock Paid-in-kind preferred stock dividend
2022-06-30
2022-05-05 4937.64 未披露 定期报告 2022-04-22
2022-05-05 4945.33 20.00
更多>>
From December 31, 2021 to March 31, 2022 Paid-in-kind preferred stock dividend Repurchase of common stock Vesting of restricted stock units Proceeds from exercise of stock options and warrants
2022-03-31
2022-03-18 4969.60 20.00 定期报告 2022-03-02
2022-02-28 4969.48 未披露 定期报告 2022-02-18
2022-02-28 4961.62 20.00
更多>>
From December 31, 2020 to December 31, 2021 Net loss Issuance of common stock for board of director compensation Issuance of common stock in public offering, net of costs of $17.7 million Issuance of common stock in direct placement, net Conversion of Series C preferred shares to common stock Paid-in-kind preferred stock dividend, including beneficial conversion feature Proceeds from exercise of stock options and warrants
2021-12-31
2021-11-12 4927.96 未披露
更多>>
1.Common stock offered 3,072,038 of shares. 2.The number of shares of common stock shown above to be outstanding after this placement is based on 46,207,566 shares outstanding as of September 30, 2021.
2021-11-12
2021-11-04 4629.57 未披露 定期报告 2021-10-29
2021-11-04 4620.76 20.00
更多>>
From June 30, 2021 to September 30, 2021 Proceeds from exercise of stock options and warrants
2021-09-30
2021-08-06 4602.25 未披露 定期报告 2021-07-30
2021-08-06 4589.24 163.50
更多>>
From March 31, 2021 to June 30, 2021 Proceeds from exercise of stock options and warrants
2021-06-30
2021-05-06 4568.15 未披露 定期报告 2021-04-23
2021-05-06 4569.37 20.00
更多>>
From December 31, 2020 to March 31, 2021 Issuance of common stock for board of director compensation Issuance of common stock in public offering, net of costs of $17.7 million Conversion of Series C preferred shares to common stock Proceeds from exercise of stock options and warrants
2021-03-31
2021-04-21 4563.50 未披露 定期报告 2021-03-10
2021-03-16 4560.46 未披露 定期报告 2021-03-05
2021-03-01 4558.17 未披露 定期报告 2021-02-19
2021-01-25 4780.33 未披露
更多>>
1.The Company completed an underwritten public offering (the “Offering”) of 4,356,059 shares of its common stock. 2.The number of shares of common stock shown above to be outstanding after this offering is based on 39,659,360 shares outstanding as of September 30, 2020 (after giving effect to the issuance of 675,536 shares of common stock in a private placement on October 1, 2020).
2021-01-25
2021-01-19 3987.72 未披露 定期报告 2021-01-14
2021-03-01 3983.71 25.00
更多>>
From December 31, 2019 to December 31, 2020 Issuance of common stock for board of director compensation Issuance of common stock in private placement, net of costs of $914,200 Issuance of Series C convertible preferred stock in private placement, net of costs of $7.7 million
2020-12-31
2020-12-15 3970.49 未披露 定期报告 2020-12-10
2020-11-06 3966.37 未披露 定期报告 2020-10-30
2020-11-06 3898.38 未披露
更多>>
From June 30, 2020 to September 30, 2020 Issuance of common stock for board of director compensation Proceeds from exercise of stock options and warrants
2020-09-30
2020-08-10 3877.80 未披露 定期报告 2020-07-31
2020-08-10 3856.52 未披露
更多>>
From March 31, 2020 to June 30, 2020 Issuance of common stock for board of director compensation Proceeds from exercise of stock options and warrants
2020-06-30
2020-05-08 3810.14 未披露 定期报告 2020-04-30
2020-05-08 3793.03 未披露
更多>>
From December 31, 2019 to March 31, 2020 Issuance of common stock for board of director compensation Proceeds from exercise of stock options and warrants
2020-03-31
2020-04-03 3767.00 未披露 定期报告 2020-03-20
2020-03-10 3764.49 未披露 定期报告 2020-03-01
2020-03-10 3733.98 未披露
更多>>
from December 31, 2018 to December 31, 2019 Proceeds from public offering net of costs of $103,000 Issuance of common stock for convertible debt and accrued interest Issuance of common stock for board of director compensation Proceeds from exercise of stock options and warrants
2019-12-31
2019-11-12 3584.35 未披露
更多>>
from June 30, 2019 to September 30, 2019 Issuance of common stock for board of director compensation Proceeds from exercise of stock options and warrants
2019-09-30
2019-08-09 3559.28 未披露 定期报告 2019-08-02
2019-08-09 3548.56 未披露
更多>>
from March 31, 2019 to June 30,2019 Proceeds from public offering, net of costs of $106,300 Issuance of common stock for board of director compensation Proceeds from exercise of stock options and warrants
2019-06-30
2019-06-24 3481.43 未披露 定期报告 2019-06-24
2019-06-19 3106.43 未披露 定期报告 2019-06-10
2019-05-09 3056.68 未披露 定期报告 2019-04-30
2019-05-09 3067.75 未披露
更多>>
from December 31, 2018 to March 31, 2019 Issuance of common stock for board of director compensation Proceeds from exercise of stock options and warrants
2019-03-31
2019-04-03 3067.62 未披露 定期报告 2019-03-27
2019-03-13 3043.63 未披露 定期报告 2019-03-01
2019-01-28 3039.92 未披露 定期报告 2019-01-24
2019-03-13 3031.90 未披露
更多>>
from December 31, 2017 to December 31, 2018 Proceeds from tender offer, net of costs of $99,357 Proceeds from ATM, net of costs of $44,202 Issuance of common stock, net of costs of $191,670 Issuance of common stock for board of director compensation Proceeds from exercise of stock options and warrants
2018-12-31
2018-11-08 2923.96 未披露 定期报告 2018-10-31
2018-11-08 2921.31 未披露 定期报告 2018-09-30
2018-08-09 2856.97 未披露 定期报告 2018-08-03
2018-08-09 2845.07 未披露 定期报告 2018-06-30
2018-05-03 2767.97 未披露 定期报告 2018-04-30
2018-05-03 2759.31 未披露 定期报告 2018-03-31
2018-04-09 2751.50 未披露 定期报告 2018-03-22
2018-03-08 2734.00 未披露 定期报告 2018-03-01
2018-03-08 2570.19 未披露
更多>>
from December 31, 2016 to December 31, 2017 Issuance of common stock for board of director compensation Proceeds from common stock offering, net of costs of $170,326 Proceeds from exercise of stock options and warrants
2017-12-31
2018-01-22 2640.57 未披露 定期报告 2017-12-15
2017-11-02 2554.09 未披露 定期报告 2017-10-31
2017-11-02 2521.75 未披露 定期报告 2017-09-30
2017-08-11 2467.44 未披露 定期报告 2017-07-28
2017-08-09 2439.93 未披露 定期报告 2017-07-25
2017-08-09 2399.25 未披露 定期报告 2017-06-30
2017-05-04 2397.57 未披露 定期报告 2017-04-30
2017-05-04 2393.77 未披露 定期报告 2017-03-31
2017-03-13 1760.43 未披露
更多>>
From March 31, 2016 to December 31, 2016 Issuance of common stock for April tender offer, net of costs of $281,500 Issuance of common stock for October tender offer, net of costs of $477,300 Issuance of common stock for Rights Offering, net of costs of $315,000 Issuance of common stock for board of director compensation
2016-12-31
2016-11-15 1759.90 未披露 定期报告 2016-11-11
2016-11-15 1512.81 未披露 定期报告 2016-09-30
2016-08-15 1512.05 未披露 定期报告 2016-06-30
2016-06-30 1511.38 未披露 定期报告 2016-06-20
2016-06-28 1427.19 未披露 定期报告 2016-06-13
2016-04-28 1427.10 未披露
更多>>
On January 30, 2016 (the “Mandatory Exchange Time”), the Company caused the mandatory exchange (the “Mandatory Exchange”) of all its outstanding Class A Convertible Preferred Stock and Class B Convertible Preferred Stock (together, the “Preferred Stock”), consisting of 454,750 shares of Class A Convertible Preferred Stock and 534,571 shares of Class B Convertible Preferred Stock, into (i) an aggregate of 4,977,038 shares (the “Shares”) of common stock, $0.001 par value per share (the “Common Stock”), of the Company and (ii) an aggregate of 4,977,038 warrants, each warrant representing the right to purchase one share of Common Stock (the “Warrants” and together with the Shares, the “Securities”).
2016-04-18
2016-06-28 1225.13 未披露
更多>>
from March 31, 2015 to March 31, 2016 Issuance of common stock in public offering, net of costs of $856,800 Mandatory conversion of Class A convertible preferred stock and Class B convertible preferred stock Issuance of common stock upon exercise of options and warrants Issuance of restricted stock in connection with consulting agreement Issuance of common stock for board of director compensation Issuance of Class B convertible preferred stock, net of offering costs of $577,700 On May 12, 2015, our Board of Directors approved an amendment to our certificate of incorporation to effect a reverse stock split by a ratio of 1-for-12. The reverse stock split was effective on May 19, 2015.
2016-03-31
2016-02-11 1224.28 未披露
更多>>
On January 30, 2016 (the “Mandatory Exchange Time”), the Company caused the mandatory exchange (the “Mandatory Exchange”) of all its outstanding Class A Convertible Preferred Stock and Class B Convertible Preferred Stock (together, the “Preferred Stock”), consisting of 454,750 shares of Class A Convertible Preferred Stock and 534,571 shares of Class B Convertible Preferred Stock, into (i) an aggregate of 4,977,038 shares (the “Shares”) of common stock, $0.001 par value per share (the “Common Stock”), of the Company and (ii) an aggregate of 4,977,038 warrants, each warrant representing the right to purchase one share of Common Stock (the “Warrants” and together with the Shares, the “Securities”).
2016-02-05
2016-02-11 724.75 98.93 定期报告 2015-12-31
2015-11-16 722.54 未披露 定期报告 2015-10-30
2015-11-16 717.04 98.93 定期报告 2015-09-30
2015-10-01 717.03 未披露 定期报告 2015-09-29
2015-08-06 715.65 未披露 定期报告 2015-07-31
2015-08-06 506.58 98.93 定期报告 2015-06-30
2015-06-22 506.12 98.93 定期报告 2015-06-10
2015-05-19 502.56 61.65
更多>>
from December 31, 2014 to May 20, 2015 Issuance of Class A convertible preferred stock, net of offering costs of $577,600 Issuance of Class A convertible preferred stock upon conversion of 5% bridge notes and accrued interest Issuance of Class B convertible preferred stock, net of offering costs of $249,000 Issuance of common stock upon exercise of options and warrants Issuance of restricted stock in connection with consulting agreement The Board of Directors authorized the twelve to one reverse stock split that became effective on May 19, 2015.
2015-05-20
2015-07-29 502.56 未披露 定期报告 2015-05-08
2015-04-17 6005.78 44.29 定期报告 2014-12-31
From December 31, 2022 to December 31, 2023 Proceeds from exercise of stock options Vesting of restricted stock units
From June 30, 2023 to September 30, 2023 Vesting of restricted stock units Proceeds from exercise of stock options
From March 31, 2023 to June 30, 2023 Proceeds from exercise of stock options Vesting of restricted stock units
From December 31, 2022 to March 31, 2023 Proceeds from exercise of stock options Vesting of restricted stock units
From December 31, 2021 to December 31, 2022 Issuance of common stock for Cell&Co acquisition Vesting of restricted stock units Proceeds from exercise of stock options Repurchase of common stock
From June 30, 2022 to September 30, 2022 Vesting of restricted stock units Proceeds from exercise of stock options
From March 31, 2022 to June 30, 2022 Issuance of common stock for Cell&Co acquisition Vesting of restricted stock units Proceeds from exercise of stock options Repurchase of common stock Paid-in-kind preferred stock dividend
From December 31, 2021 to March 31, 2022 Paid-in-kind preferred stock dividend Repurchase of common stock Vesting of restricted stock units Proceeds from exercise of stock options and warrants
From December 31, 2020 to December 31, 2021 Net loss Issuance of common stock for board of director compensation Issuance of common stock in public offering, net of costs of $17.7 million Issuance of common stock in direct placement, net Conversion of Series C preferred shares to common stock Paid-in-kind preferred stock dividend, including beneficial conversion feature Proceeds from exercise of stock options and warrants
1.Common stock offered 3,072,038 of shares. 2.The number of shares of common stock shown above to be outstanding after this placement is based on 46,207,566 shares outstanding as of September 30, 2021.
From June 30, 2021 to September 30, 2021 Proceeds from exercise of stock options and warrants
From March 31, 2021 to June 30, 2021 Proceeds from exercise of stock options and warrants
From December 31, 2020 to March 31, 2021 Issuance of common stock for board of director compensation Issuance of common stock in public offering, net of costs of $17.7 million Conversion of Series C preferred shares to common stock Proceeds from exercise of stock options and warrants
1.The Company completed an underwritten public offering (the “Offering”) of 4,356,059 shares of its common stock. 2.The number of shares of common stock shown above to be outstanding after this offering is based on 39,659,360 shares outstanding as of September 30, 2020 (after giving effect to the issuance of 675,536 shares of common stock in a private placement on October 1, 2020).
From December 31, 2019 to December 31, 2020 Issuance of common stock for board of director compensation Issuance of common stock in private placement, net of costs of $914,200 Issuance of Series C convertible preferred stock in private placement, net of costs of $7.7 million
From June 30, 2020 to September 30, 2020 Issuance of common stock for board of director compensation Proceeds from exercise of stock options and warrants
From March 31, 2020 to June 30, 2020 Issuance of common stock for board of director compensation Proceeds from exercise of stock options and warrants
From December 31, 2019 to March 31, 2020 Issuance of common stock for board of director compensation Proceeds from exercise of stock options and warrants
from December 31, 2018 to December 31, 2019 Proceeds from public offering net of costs of $103,000 Issuance of common stock for convertible debt and accrued interest Issuance of common stock for board of director compensation Proceeds from exercise of stock options and warrants
from June 30, 2019 to September 30, 2019 Issuance of common stock for board of director compensation Proceeds from exercise of stock options and warrants
from March 31, 2019 to June 30,2019 Proceeds from public offering, net of costs of $106,300 Issuance of common stock for board of director compensation Proceeds from exercise of stock options and warrants
from December 31, 2018 to March 31, 2019 Issuance of common stock for board of director compensation Proceeds from exercise of stock options and warrants
from December 31, 2017 to December 31, 2018 Proceeds from tender offer, net of costs of $99,357 Proceeds from ATM, net of costs of $44,202 Issuance of common stock, net of costs of $191,670 Issuance of common stock for board of director compensation Proceeds from exercise of stock options and warrants
from December 31, 2016 to December 31, 2017 Issuance of common stock for board of director compensation Proceeds from common stock offering, net of costs of $170,326 Proceeds from exercise of stock options and warrants
From March 31, 2016 to December 31, 2016 Issuance of common stock for April tender offer, net of costs of $281,500 Issuance of common stock for October tender offer, net of costs of $477,300 Issuance of common stock for Rights Offering, net of costs of $315,000 Issuance of common stock for board of director compensation
On January 30, 2016 (the “Mandatory Exchange Time”), the Company caused the mandatory exchange (the “Mandatory Exchange”) of all its outstanding Class A Convertible Preferred Stock and Class B Convertible Preferred Stock (together, the “Preferred Stock”), consisting of 454,750 shares of Class A Convertible Preferred Stock and 534,571 shares of Class B Convertible Preferred Stock, into (i) an aggregate of 4,977,038 shares (the “Shares”) of common stock, $0.001 par value per share (the “Common Stock”), of the Company and (ii) an aggregate of 4,977,038 warrants, each warrant representing the right to purchase one share of Common Stock (the “Warrants” and together with the Shares, the “Securities”).
from March 31, 2015 to March 31, 2016 Issuance of common stock in public offering, net of costs of $856,800 Mandatory conversion of Class A convertible preferred stock and Class B convertible preferred stock Issuance of common stock upon exercise of options and warrants Issuance of restricted stock in connection with consulting agreement Issuance of common stock for board of director compensation Issuance of Class B convertible preferred stock, net of offering costs of $577,700 On May 12, 2015, our Board of Directors approved an amendment to our certificate of incorporation to effect a reverse stock split by a ratio of 1-for-12. The reverse stock split was effective on May 19, 2015.
On January 30, 2016 (the “Mandatory Exchange Time”), the Company caused the mandatory exchange (the “Mandatory Exchange”) of all its outstanding Class A Convertible Preferred Stock and Class B Convertible Preferred Stock (together, the “Preferred Stock”), consisting of 454,750 shares of Class A Convertible Preferred Stock and 534,571 shares of Class B Convertible Preferred Stock, into (i) an aggregate of 4,977,038 shares (the “Shares”) of common stock, $0.001 par value per share (the “Common Stock”), of the Company and (ii) an aggregate of 4,977,038 warrants, each warrant representing the right to purchase one share of Common Stock (the “Warrants” and together with the Shares, the “Securities”).
from December 31, 2014 to May 20, 2015 Issuance of Class A convertible preferred stock, net of offering costs of $577,600 Issuance of Class A convertible preferred stock upon conversion of 5% bridge notes and accrued interest Issuance of Class B convertible preferred stock, net of offering costs of $249,000 Issuance of common stock upon exercise of options and warrants Issuance of restricted stock in connection with consulting agreement The Board of Directors authorized the twelve to one reverse stock split that became effective on May 19, 2015.